CIGNA Establishes Positive Coverage for MIS SI Joint Fusion

CIGNA announced a positive coverage policy for minimally invasive sacroiliac (SI) joint fusion exclusive for FDA-cleared implants that are placed across the SI joint to promote bone fusion, such as SI-BONE's iFuse Implant System.

CIGNA, the fourth-largest U.S. commercial health plan, covers nearly 15 million lives.

“As a result of this...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us